AURORA, ON–(Marketwired – Dec 6, 2013) – Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced that it has terminated its employment of John Docherty, effective immediately.
6 December 2013